Jay B. Hann

Array ( [id] => 4011053 [patent_doc_number] => 05879911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Cell surface protein expressed on human cortical thymocyte and their use' [patent_app_type] => 1 [patent_app_number] => 8/782682 [patent_app_country] => US [patent_app_date] => 1997-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5756 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879911.pdf [firstpage_image] =>[orig_patent_app_number] => 782682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834778 [patent_doc_number] => 05846739 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Immunohistochemical detection assay for carcinoma proliferative status' [patent_app_type] => 1 [patent_app_number] => 8/779870 [patent_app_country] => US [patent_app_date] => 1997-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2441 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846739.pdf [firstpage_image] =>[orig_patent_app_number] => 779870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3882093 [patent_doc_number] => 05714148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Chemical compounds' [patent_app_type] => 1 [patent_app_number] => 8/722669 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22930 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1039 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714148.pdf [firstpage_image] =>[orig_patent_app_number] => 722669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881682 [patent_doc_number] => 05723125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide' [patent_app_type] => 1 [patent_app_number] => 8/719331 [patent_app_country] => US [patent_app_date] => 1996-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4618 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723125.pdf [firstpage_image] =>[orig_patent_app_number] => 719331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874650 [patent_doc_number] => 05747332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Methods for purifying and synthesizing heat shock protein complexes' [patent_app_type] => 1 [patent_app_number] => 8/717239 [patent_app_country] => US [patent_app_date] => 1996-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2305 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747332.pdf [firstpage_image] =>[orig_patent_app_number] => 717239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3851651 [patent_doc_number] => 05705154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Humanized monoclonal antibodies against human interleukin-4' [patent_app_type] => 1 [patent_app_number] => 8/704744 [patent_app_country] => US [patent_app_date] => 1996-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20233 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705154.pdf [firstpage_image] =>[orig_patent_app_number] => 704744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662438 [patent_doc_number] => 05667978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Antibody to the neural cell adhesion molecule and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/642288 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4153 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667978.pdf [firstpage_image] =>[orig_patent_app_number] => 642288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725140 [patent_doc_number] => 05651969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Antibody to the neural cell adhesion molecule and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/642374 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4146 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/651/05651969.pdf [firstpage_image] =>[orig_patent_app_number] => 642374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743715 [patent_doc_number] => 05801145 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Method for selectively purging CD77+ cells from bone marrow' [patent_app_type] => 1 [patent_app_number] => 8/599211 [patent_app_country] => US [patent_app_date] => 1996-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4457 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801145.pdf [firstpage_image] =>[orig_patent_app_number] => 599211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656757 [patent_doc_number] => 05627034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Assay for carcinoma proliferative status by measuring NGAL expression level' [patent_app_type] => 1 [patent_app_number] => 8/567509 [patent_app_country] => US [patent_app_date] => 1995-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4371 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627034.pdf [firstpage_image] =>[orig_patent_app_number] => 567509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831017 [patent_doc_number] => 05712120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/497312 [patent_app_country] => US [patent_app_date] => 1995-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8032 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712120.pdf [firstpage_image] =>[orig_patent_app_number] => 497312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810935 [patent_doc_number] => 05770196 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Modified antibody variable domains and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/472788 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 27796 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770196.pdf [firstpage_image] =>[orig_patent_app_number] => 472788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781580 [patent_doc_number] => 05821123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Modified antibody variable domains' [patent_app_type] => 1 [patent_app_number] => 8/477531 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 21757 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821123.pdf [firstpage_image] =>[orig_patent_app_number] => 477531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775631 [patent_doc_number] => 05808033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Family of anti-carcinoembryonic antigen chimeric antibodies' [patent_app_type] => 1 [patent_app_number] => 8/471426 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12359 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808033.pdf [firstpage_image] =>[orig_patent_app_number] => 471426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783315 [patent_doc_number] => 05821238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Recombinant pseudomonas exotoxin with increased activity' [patent_app_type] => 1 [patent_app_number] => 8/461234 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 12167 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821238.pdf [firstpage_image] =>[orig_patent_app_number] => 461234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696612 [patent_doc_number] => 05645817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Granulocyte-binding antibody constructs, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/459310 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4005 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645817.pdf [firstpage_image] =>[orig_patent_app_number] => 459310 [rel_patent_id] =>[rel_patent_doc_number] =>)